Corcept Therapeutics · 1 day ago
Associate Director, Field Reimbursement Lead
Corcept Therapeutics is a leader in the research and development of cortisol modulators, with a focus on treating serious diseases. The Associate Director, Field Reimbursement Lead will manage a team of Field Reimbursement Managers, ensuring effective operations and alignment with national strategies while addressing complex access and reimbursement issues.
BiotechnologyMedicalPharmaceutical
Responsibilities
Directly manage, mentor, and develop the FRMs in assigned region, providing regular coaching, performance feedback, and professional development
Recruit, onboard, and train new FRMs in assigned region; ensure they get ramped up rapidly
Develop and monitor regional metrics (e.g. enrollment volumes, turnaround times, PA and appeal success rates, pull-through) and hold FRMs accountable to targets
Oversee the regional FRM MBO / incentive compensation plan to ensure alignment with national goals and motivate top performance
Serve as the escalation point for issues that FRMs can’t resolve, particularly around complex payer denials, appeals, specialty pharmacy issues, or HUB handoffs
Conduct regular ride-alongs / field visits with FRMs to evaluate best practices, understand account dynamics, and identify coaching opportunities
Translate national field access strategy into actionable regional plans for your FRM team
Periodically evaluate territory alignments, resource allocation, and coverage gaps; recommend adjustments to optimize performance
Use data analytics and field feedback to identify regional access barriers, trends, and opportunities; propose and lead regional solutions or pilots
Lead regional team meetings, forums for shared learnings, and best-practice dissemination
Collaborate with the Senior Director / Director to shape national access initiatives and share insights from your region
Partner closely with Regional Sales Leadership to align account priorities, pull-through strategies, and access tactics
Coordinate with HUB leadership, Specialty Pharmacies, Market Access, Legal/Compliance, and Patient Services to ensure smooth operations and escalation pathways
Represent your region in cross-functional review meetings, bringing forth region-specific insights, challenges, and recommendations
Interface with internal functions (e.g. analytics marketing, training) to ensure FRMs have the tools, materials, and knowledge they need
Monitor active cases across the region for escalations, bottlenecks, and risk of enrollment cancellation or therapy discontinuation
Lead or coordinate regional escalation reviews for high-risk patient cases or payer denials
Ensure best-practice approaches are documented and shared across teams
Qualification
Required
Experience in rare disease, endocrinology, or high complexity access therapeutic areas
Prior experience managing teams of FRMs, Access Specialists, or analogous roles
Experience working in launch or post-launch access environments
Exposure to incentive compensation / MBO design oversight
Deep familiarity with U.S. payer/reimbursement landscape, HUB operations, specialty pharmacy models, appeals, prior authorization workflows, etc
Proven ability to drive results through others, influence cross-functional stakeholders, and manage conflict
Strong analytics mindset, data-driven decision making, and ability to turn insights into action
Excellent communication, collaboration, and interpersonal skills
Bachelor's degree required; advanced degree (MBA, MPH, PharmD) preferred
10+ years of experience in pharmaceuticals, biotech, healthcare, or reimbursement/access roles
At least 3+ years of direct leadership or management experience, ideally managing field teams (FRMs, access, patient services, or related roles)
Ability to travel extensively (up to 60%) within region, with frequent field engagements
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Recent News
2026-01-07
Company data provided by crunchbase